Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.365 USD | -0.15% | -2.32% | +103.01% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+103.01% | 209M | |
+24.05% | 48.09B | |
+46.90% | 40.62B | |
-2.63% | 40.43B | |
-6.95% | 28.36B | |
+7.57% | 24.89B | |
-19.51% | 19.01B | |
+29.06% | 12.09B | |
-0.03% | 11.88B | |
-0.71% | 11.8B |
- Stock Market
- Equities
- GALT Stock
- News Galectin Therapeutics Inc.
- Galectin Therapeutics Cleared by DSMB to Continue Belapectin Study in Patients with Liver Cirrhosis Caused by NASH